[Experience with the thrombolytic therapy of myocardial infarct].
Gospodarenko
A L
AL
Ardashev
V N
VN
Tiurin
V P
VP
Chernetsov
V A
VA
Iakovlev
V B
VB
Vrublevskiĭ
O Iu
OIu
Makarenko
A S
AS
Sokolianskiĭ
N V
NV
Chernov
S A
SA
Kucherov
V V
VV
Davrent'eva
T A
TA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004562:Electrocardiography / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008889:Military Personnel; D009203:Myocardial Infarction / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D012426:Russia; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator
Opyt tromboliticheskoĭ terapii infarkta miokarda.